FEMORAL ARTERY OCCLUSION side effect
What is FEMORAL ARTERY OCCLUSION ?Drugs associated with FEMORAL ARTERY OCCLUSION
AMEVIVE BEXTRA CILOSTAZOL DOCETAXEL DOXORUBICIN HALDOL IMMUNOSPORIN LIPITOR LUPRON PANITUMUMAB TIOTROPIUM ZEMPLARFEMORAL ARTERY OCCLUSION : Amevive Side Effects Report #5678415-3
Consumer or non-health professional from UNITED STATES reported AMEVIVE problem on Mar 04, 2008. Female patient, 71 years of age, weighting 149.9 lb, was diagnosed with psoriasis and was treated with AMEVIVE. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, . AMEVIVE dosage: 15 MG, WEEKLY, INTRAMUSCULAR. Patient was hospitalized. Patient recovered.
FEMORAL ARTERY OCCLUSION : Zemplar Side Effects Report #5684987-5
ZEMPLAR problem was reported by a Physician from GREECE on Mar 26, 2008. Female patient, 62 years of age, weighting 137.8 lb, was diagnosed with hyperparathyroidism secondary, anaemia, carnitine decreased, vitamin supplementation, peripheral vascular disorder, coronary artery disease, hyperphosphataemia and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, gangrene, pneumonia, sepsis, . ZEMPLAR dosage: unknown. During the same period patient was treated with EPOETIN BETA, INTELLECTA, CERNEVIT, BUFLOMEDIL HYDROCHLORIDE, ACETYLSALICYLIC ACID SRT, FORSENOL. Patient was hospitalized. Patient died on 09/23/2007.
FEMORAL ARTERY OCCLUSION : Tiotropium Side Effects Report #5599008-2
Consumer or non-health professional from reported TIOTROPIUM problem on Jan 16, 2008. Male patient, 63 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with TIOTROPIUM. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, . TIOTROPIUM dosage: unknown. Patient was hospitalized. Patient recovered.
FEMORAL ARTERY OCCLUSION : Cilostazol Side Effects Report #5603350-6
CILOSTAZOL problem was reported by a Consumer or non-health professional from GERMANY on Jan 07, 2008. Female patient, 67 years of age, was diagnosed with intermittent claudication and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, . CILOSTAZOL dosage: 200 MG ORAL. During the same period patient was treated with PENTAERITHRITYL TETRANITRATE, ENALAPRIL, METOPROLOL TARTRATE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
FEMORAL ARTERY OCCLUSION : Lipitor Side Effects Report #5605337-6
Consumer or non-health professional from UNITED STATES reported LIPITOR problem on Jan 16, 2008. Female patient, weighting 140.3 lb, was treated with LIPITOR. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, pain in extremity, restless legs syndrome, sleep disorder, . LIPITOR dosage: unknown. During the same period patient was treated with CHANTIX, FORADIL, PREVACID, ACTONEL, ATROVENT. Patient recovered.
FEMORAL ARTERY OCCLUSION : Cilostazol Side Effects Report #5567396-9
CILOSTAZOL problem was reported by a Consumer or non-health professional from GERMANY on Dec 03, 2007. Female patient, 60 years of age, was diagnosed with intermittent claudication and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, iliac artery occlusion, reocclusion, . CILOSTAZOL dosage: 50 MG/100 MG/200 MG ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.
FEMORAL ARTERY OCCLUSION : Bextra Side Effects Report #5596031-9
Consumer or non-health professional from UNITED STATES reported BEXTRA problem on Mar 12, 2007. Female patient, 64 years of age, weighting 140.0 lb, was treated with BEXTRA. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, . BEXTRA dosage: unknown. Patient was hospitalized. Patient recovered.
FEMORAL ARTERY OCCLUSION : Docetaxel Side Effects Report #5505993-7
DOCETAXEL problem was reported by a Physician from UNITED STATES on Nov 01, 2007. Female patient, 57 years of age, weighting 210.3 lb, was diagnosed with breast cancer and was treated with DOCETAXEL. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, . DOCETAXEL dosage: 60MG/M2 1 Q 3 WEEKS IV. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
FEMORAL ARTERY OCCLUSION : Tiotropium Side Effects Report #5511851-4
Consumer or non-health professional from reported TIOTROPIUM problem on Nov 05, 2007. Male patient, 63 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with TIOTROPIUM. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, . TIOTROPIUM dosage: unknown. Patient was hospitalized. Patient recovered.
FEMORAL ARTERY OCCLUSION : Amevive Side Effects Report #5452040-1
AMEVIVE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2007. Female patient, 71 years of age, weighting 149.9 lb, was diagnosed with psoriasis and was treated with AMEVIVE. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, . AMEVIVE dosage: 15 MG, WEEKLY, INTRAMUSCULAR. Patient was hospitalized. Patient recovered.
FEMORAL ARTERY OCCLUSION : Zemplar Side Effects Report #5471250-0
Physician from GREECE reported ZEMPLAR problem on Sept 24, 2007. Female patient, 62 years of age, weighting 137.8 lb, was diagnosed with hyperparathyroidism secondary, anaemia, carnitine decreased, vitamin supplementation, peripheral vascular disorder, coronary artery disease, hyperphosphataemia and was treated with ZEMPLAR. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, gangrene, pneumonia, sepsis, . ZEMPLAR dosage: unknown. During the same period patient was treated with EPOETIN BETA, INTELLECTA, CERNEVIT, BUFLOMEDIL HYDROCHLORIDE, ASPIRIN, FORSENOL. Patient was hospitalized. Patient died on 09/23/2007.
FEMORAL ARTERY OCCLUSION : Panitumumab Side Effects Report #5386520-4
PANITUMUMAB problem was reported by a Physician from POLAND on July 03, 2007. Female patient was diagnosed with colorectal cancer and was treated with PANITUMUMAB. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, iliac artery embolism, peripheral arterial occlusive disease, . PANITUMUMAB dosage: unknown. Patient was hospitalized. Patient recovered.
FEMORAL ARTERY OCCLUSION : Panitumumab Side Effects Report #5386520-4
Physician from POLAND reported PANITUMUMAB problem on July 03, 2007. Female patient was diagnosed with colorectal cancer and was treated with PANITUMUMAB. After drug was administered, patient experienced the following problems/side effects: femoral artery occlusion, iliac artery embolism, peripheral arterial occlusive disease, . PANITUMUMAB dosage: unknown. Patient was hospitalized. Patient recovered.
FEMORAL ARTERY OCCLUSION : Doxorubicin Side Effects Report #5519206-3
DOXORUBICIN problem was reported by a Physician from UNITED STATES on Nov 14, 2007. Female patient, 57 years of age, weighting 209.4 lb, was diagnosed with breast cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: arterial thrombosis limb, femoral artery occlusion, . DOXORUBICIN dosage: 60MG/M2 IVQ3WK. During the same period patient was treated with CYCLOPHOSPHAMIDE, ASPIRIN, HYDROCHLOROTHIAZIDE, FLUOXETINE, APREPITANT, PROCHLORPERAZINE, ONDANSETRON. Patient was hospitalized. Patient recovered.
FEMORAL ARTERY OCCLUSION : Haldol Side Effects Report #5527887-3
Physician from SWITZERLAND reported HALDOL problem on Nov 23, 2007. Male patient, 83 years of age, weighting 176.4 lb, was diagnosed with agitation and was treated with HALDOL. After drug was administered, patient experienced the following problems/side effects: erythema, femoral artery occlusion, neuroleptic malignant syndrome, panniculitis, pleural effusion, . HALDOL dosage: unknown. During the same period patient was treated with CITALOPRAM, LEXOTANIL. Patient was hospitalized. Patient died on 09/18/2007.
FEMORAL ARTERY OCCLUSION : Lupron Side Effects Report #5378522-9
LUPRON DEPOT problem was reported by a Health Professional from CANADA on June 26, 2007. Male patient, 78 years of age, weighting 165.3 lb, was diagnosed with prostate cancer and was treated with LUPRON DEPOT. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, femoral artery occlusion, . LUPRON DEPOT dosage: 7.5 MG, 1 IN 1 M, INTRAMUSCULAR. Patient recovered.
FEMORAL ARTERY OCCLUSION : Lupron Side Effects Report #5378522-9
Health Professional from CANADA reported LUPRON DEPOT problem on June 26, 2007. Male patient, 78 years of age, weighting 165.3 lb, was diagnosed with prostate cancer and was treated with LUPRON DEPOT. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, femoral artery occlusion, . LUPRON DEPOT dosage: 7.5 MG, 1 IN 1 M, INTRAMUSCULAR. Patient recovered.
FEMORAL ARTERY OCCLUSION : Immunosporin Side Effects Report #5605854-9
IMMUNOSPORIN problem was reported by a Physician from GERMANY on Jan 22, 2008. Female patient, 65 years of age, was diagnosed with prurigo and was treated with IMMUNOSPORIN. After drug was administered, patient experienced the following problems/side effects: arterial occlusive disease, atrial fibrillation, femoral artery occlusion, hypertension, peripheral embolism, . IMMUNOSPORIN dosage: 200 MG, BID. Patient was hospitalized. Patient recovered.
FEMORAL ARTERY OCCLUSION : Cilostazol Side Effects Report #5533914-X
Consumer or non-health professional from JAPAN reported CILOSTAZOL problem on Nov 15, 2007. Male patient, 73 years of age, was diagnosed with cerebral infarction and was treated with CILOSTAZOL. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm, arteriosclerosis obliterans, femoral artery occlusion, iliac artery stenosis, peripheral artery dissection, . CILOSTAZOL dosage: ONE OF 200 MG OR 81 MG. During the same period patient was treated with GLIBENCLAMIDE, VOGLIBOSE, LOSARTAN POTASSIUM. Patient was hospitalized. Patient recovered.